Adjuvant Tebentafusp in High Risk Ocular Melanoma
Clinical trial NCT06246149 · RECRUITING
Trial details
- NCT number
- NCT06246149
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2032-11-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.